acridine orange has been researched along with pyrazines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burckhardt, G; Sabolić, I | 1 |
| Chen, KF; Cheng, AL; Hou, DR; Lin, CS; Liu, CY; Shiau, CW; Yu, HC | 1 |
2 other study(ies) available for acridine orange and pyrazines
| Article | Year |
|---|---|
Apparent inhibition of Na+/H+ exchange by amiloride and harmaline in acridine orange studies.
Topics: Acridine Orange; Alkaloids; Amiloride; Animals; Carrier Proteins; Cell Membrane; Harmaline; Hydrogen-Ion Concentration; Kidney Cortex; Kinetics; Microvilli; Potassium; Pyrazines; Rats; Sodium-Hydrogen Exchangers | 1983 |
Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.
Topics: Acridine Orange; Autoantigens; Autophagy; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Membrane Proteins; Microscopy, Fluorescence; Phosphorylation; Proteasome Endopeptidase Complex; Protein Phosphatase 2; Pyrazines; Time Factors | 2013 |